Cellebrite DI Ltd. $CLBT Shares Acquired by Sigma Planning Corp

Sigma Planning Corp increased its holdings in shares of Cellebrite DI Ltd. (NASDAQ:CLBT) by 100.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 24,000 shares of the company’s stock after acquiring an additional 12,000 shares during the period. Sigma Planning Corp’s holdings in Cellebrite DI were worth $384,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of CLBT. Redmond Asset Management LLC grew its stake in shares of Cellebrite DI by 65.9% during the 2nd quarter. Redmond Asset Management LLC now owns 189,637 shares of the company’s stock worth $3,034,000 after purchasing an additional 75,320 shares during the period. Motley Fool Wealth Management LLC purchased a new stake in Cellebrite DI during the second quarter worth about $6,117,000. Teacher Retirement System of Texas grew its position in Cellebrite DI by 3.7% during the second quarter. Teacher Retirement System of Texas now owns 46,065 shares of the company’s stock worth $737,000 after buying an additional 1,658 shares during the period. Y Intercept Hong Kong Ltd purchased a new position in Cellebrite DI in the second quarter valued at about $657,000. Finally, MQS Management LLC acquired a new stake in shares of Cellebrite DI during the 2nd quarter valued at approximately $256,000. Institutional investors and hedge funds own 45.88% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the company. Needham & Company LLC lowered their price target on Cellebrite DI from $24.00 to $18.00 and set a “buy” rating on the stock in a report on Thursday, August 14th. JPMorgan Chase & Co. upped their target price on Cellebrite DI from $20.00 to $23.00 and gave the company an “overweight” rating in a report on Wednesday, September 24th. Wall Street Zen cut Cellebrite DI from a “buy” rating to a “hold” rating in a research report on Saturday. Weiss Ratings upgraded shares of Cellebrite DI from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday. Finally, Lake Street Capital lowered their price objective on shares of Cellebrite DI from $24.00 to $22.00 and set a “buy” rating on the stock in a research note on Friday, August 15th. Three investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $21.00.

Cellebrite DI Stock Up 0.9%

NASDAQ CLBT opened at $15.40 on Monday. The stock has a market cap of $3.69 billion, a price-to-earnings ratio of -20.26, a price-to-earnings-growth ratio of 3.16 and a beta of 1.28. Cellebrite DI Ltd. has a fifty-two week low of $13.10 and a fifty-two week high of $26.30. The business has a fifty day moving average of $17.76 and a 200-day moving average of $16.75.

Cellebrite DI (NASDAQ:CLBT) last posted its quarterly earnings data on Thursday, August 14th. The company reported $0.12 EPS for the quarter, topping analysts’ consensus estimates of $0.11 by $0.01. The firm had revenue of $113.28 million during the quarter, compared to analysts’ expectations of $112.33 million. Cellebrite DI had a positive return on equity of 23.92% and a negative net margin of 34.56%.The firm’s quarterly revenue was up 18.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.10 EPS. Cellebrite DI has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, analysts anticipate that Cellebrite DI Ltd. will post 0.3 EPS for the current year.

Cellebrite DI Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.